These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2918497)

  • 1. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
    Bovy PR; Trapani AJ; McMahon EG; Palomo M
    J Med Chem; 1989 Mar; 32(3):520-2. PubMed ID: 2918497
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
    J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
    Bravo EL; Khosla MC; Bumpus FM
    Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of angiotensin antagonists in normotensive rats.
    Sen S; Tarazi RC; Bumpus FM
    Clin Sci (Lond); 1979 May; 56(5):439-43. PubMed ID: 157829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An angiotensin II antagonist with strongly prolonged action.
    Holck M; Bossé R; Fischli W; Gerold H; Escher E
    Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
    Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
    Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 9. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
    Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ
    Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of [1-Aib]-angiotensin II, an analogue with higher potency than [1-Asn,5-Val]-angiotensin II.
    Cordopatis P; Theodoropoulos D
    Experientia; 1983 Jan; 39(1):106-8. PubMed ID: 6825770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of angiotensin II analogues containing a Val-His replacement, Val psi[CH(CONH2)NH]His.
    Mohan R; Chou YL; Bihovsky R; Lumma WC; Erhardt PW; Shaw KJ
    J Med Chem; 1991 Aug; 34(8):2402-10. PubMed ID: 1875337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure dependence of angiotensin tachyphylaxis and the mechanisms of saralasin like and sarmesin like antagonism.
    Moore GJ; Franklin KJ; Nystrom DM
    Proc West Pharmacol Soc; 1985; 28():31-3. PubMed ID: 3840898
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New angiotensin analogues: 8-(L-alpha-methyl-3,4-dihydroxyphenylalanine)-angiotensin II.
    Arakawa K; Hirata M; Watanabe K; Kuga H; Hattori E
    Chem Pharm Bull (Tokyo); 1979 Apr; 27(3):1030-3. PubMed ID: 476857
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypoxic pulmonary vasoconstriction and angiotensin II blockade in calves (author's transl)].
    Mattioli L; Zakheim RM; Toyama M; Park MK; Molteni A; Vaseenon T; Nicolosi GL; Zanuttini D
    G Ital Cardiol; 1979; 9(12):1382-5. PubMed ID: 549786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two angiotensin II analogous on blood pressure in normal subjects with various sodium balances.
    Ogihara T; Hata T; Mikami H; Mandai T; Kumahara Y
    Life Sci; 1977 Jun; 20(11):1855-61. PubMed ID: 875624
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologically active derivatives of angiotensin for labeling cellular receptors.
    Galardy RE; Stafford SS; Schaefer ML; Ho H; La Vorgna KA; Jamieson JD
    J Med Chem; 1978 Dec; 21(12):1279-83. PubMed ID: 214560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.